Go Pro
NYSEARCA:LABU

Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News

Direxion Daily S&P Biotech Bull 3x Shares logo
$274.05 +1.21 (+0.44%)
As of 04:10 PM Eastern

About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

Advanced

Key Stats

Today's Range
$264.00
$277.46
50-Day Range
$156.84
$324.26
52-Week Range
$58.35
$333.00
Volume
402,962 shs
Average Volume
623,091 shs
Market Capitalization
$635.80 million
Assets Under Management
$633.52 million
Dividend Yield
0.37%
Net Expense Ratio
0.93%
Aggregate Rating
Moderate Buy

ETF Overview

Direxion Daily S&P Biotech Bull 3x Shares Expenses

TypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.75%0.56%0.57%0.51%0.53%
Other Expenses0.18%0.47%0.55%0.58%0.55%
Total Expense0.93%0.74%0.76%0.74%0.73%
Fee Waiver0.00%-0.71%-0.64%-0.70%-0.62%
Net Expense0.93%0.59%0.63%0.58%0.60%
Receive LABU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LABU ETF News Headlines

Jeff Brown and Marc Chaikin's latest AI prediction explained
Jeff Brown and Marc Chaikin - the duo who identified Nvidia a decade ago - are forecasting that Elon Musk's AI breakthrough they call 'M.A.G.I.' will collide with a rare market pattern by July 30. That pattern carries a 100% historical track record. The last time it triggered, early investors had a chance to turn $10,000 into as much as $350,000 in roughly 12 months.tc pixel
See More Headlines

LABU ETF - Frequently Asked Questions

Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $159.39 at the start of the year. Since then, LABU shares have increased by 71.9% and is now trading at $274.05.

Shares of Direxion Daily S&P Biotech Bull 3x Shares reverse split before market open on Monday, December 4th 2023.The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Direxion Daily S&P Biotech Bull 3x Shares' top institutional investors include Ramsey Quantitative Systems (0.01%).

Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AT&T (T), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and Advanced Micro Devices (AMD).

Fund Details

Issuer
Direxion
Fund Name
Direxion Daily S&P Biotech Bull 3x Shares
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:LABU
Inception Date
5/28/2015
Fund Manager
Paul Brigandi, Tony Ng
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotechnology Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
182

Fund Statistics

Assets Under Management
$633.52 million
Average Daily Volume
$609.39 thousand
Discount/Premium
0.30%
Leveraged
3.00

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Rafferty Asset Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
2,999
Put Options
1,362
Call Options
1,637
Short Interest
567,714 shs

Miscellaneous

Beta
2.39
Creation Unit
50,000
Creation Fee
$250.00
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Top 10 LABU Holdings

  • Dreyfus Govt Cash Man Ins
    Holding Weight: 26.83%
  • Goldman Finl Sq Trsry Inst 506
    Holding Weight: 15.94%
  • S&P Biotechnology Select Industry Index Swap
    Holding Weight: 9.47%
  • S&P Biotechnology Select Industry Index Swap
    Holding Weight: 7.35%
  • S&P Biotechnology Select Industry Index Swap
    Holding Weight: 6.75%
  • S&P Biotechnology Select Industry Index Swap
    Holding Weight: 4.85%
  • S&P Biotechnology Select Industry Index Swap
    Holding Weight: 3.87%
  • Goldman Sachs Fin Gov 465 Institut
    Holding Weight: 3.42%
  • S&P Biotechnology Select Industry Index Swap
    Holding Weight: 2.19%
  • Apogee Therapeutics (NASDAQ:APGE)
    Holding Weight: 0.76%

LABU Sector Exposure

LABU Industry Exposure


This page (NYSEARCA:LABU) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners